Letter

New ABPI code provides more information for patients

BMJ 2005; 331 doi: 10.1136/bmj.331.7529.1409 (Published 8 December 2005)
Cite this as: BMJ 2005;331:1409.1

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Richard Barker, director general (rley@abpi.org.uk)
  1. Association of the British Pharmaceutical Industry (ABPI), London SW1A 2DY

    Editor—Shaw et al highlight the benefits that will result if the pharmaceutical industry is enabled to communicate better with those who are its ultimate customers—patients.1

    The revised ABPI (Association of the British Pharmaceutical Industry) code addresses in more detail the provision of information to the public. As for the current code, information must be factual and presented …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular